Par Pharmaceutical Competitors and Similar CompaniesClear all

Cipla's competitors and similar companies include Hikma Pharmaceuticals, Teva and Sun Pharma.

	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.	Teva Teva is a pharmaceuticals company.	Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
Founding Date	Founding Date 1935	Founding Date 1978	Founding Date 1901	Founding Date 1983
Type	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare drug development pharma
Locations	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more	Locations HQ	Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more
Employees	Employees 27,764	Employees 9,500	Employees 29,780	Employees 43,000
Financial
Revenue (est.)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) $3.3b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹582.2b (FY, 2026)
Cost of goods	Cost of goods ₹97.2b (FY, 2026)	Cost of goods $1.7b (FY, 2025)	Cost of goods N/A	Cost of goods ₹115.4b (FY, 2026)
Gross profit	Gross profit ₹184.4b (FY, 2026)	Gross profit $1.7b (FY, 2025)	Gross profit N/A	Gross profit ₹488.9b (FY, 2026)
Net income	Net income ₹38.7b (FY, 2026)	Net income $407m (FY, 2025)	Net income N/A	Net income ₹115.6b (FY, 2026)
Operating ⚠
Manufacturing Sites	Manufacturing Sites 46 (FY, 2024)	Manufacturing Sites N/A	Manufacturing Sites N/A	Manufacturing Sites 40 (FY, 2025)